Genelux Corporation (GNLX)
NASDAQ · Manufacturing · Pharmaceutical preparations
GNLX price, last 12 months
Key stats
- Previous close
- $2.24
- Open
- $2.22
- Day range
- $2.11 – $2.32
- 52-week range
- $1.77 – $5.89
- Volume
- 210.2K
- Avg volume (20 days)
- 380.3K
- Market cap
- $84.4M
Performance
Technicals and fundamentals
About Genelux Corporation
Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $84.4M